SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : PlanetRx.com Inc-(PLRX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Hua who wrote (16)10/7/1999 7:49:00 AM
From: Old Stock Collector  Read Replies (1) of 79
 
Thursday October 7, 6:00 am Eastern Time Company Press Release
SOURCE: PlanetRx.com, Inc.
PlanetRx.com Announces Initial Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 7 /PRNewswire/ -- PlanetRx.com, Inc. (Nasdaq: PLRX - news) announced today its initial public offering of 6,000,000 shares of its common stock at an initial public offering price of $16.00 per share. All of the shares are being sold by PlanetRx.com. The shares are being offered through underwriters led by Goldman, Sachs & Co., BancBoston Robert Stephens, Hambrecht & Quist and William Blair & Company. In addition, the underwriters will have a 30-day option to purchase up to 900,000 additional shares of common stock to cover over-allotments; if any.

PlanetRx.com is a leading online healthcare destination for commerce, content and community. Its e-commerce website, www.planetrx.com, provides a convenient, private and informative shopping experience. PlanetRx.com offers products in six categories: prescription drugs; non-prescription drugs; personal care; beauty and spa; vitamins, herbs and nutrition; and medical supplies.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

A copy of the final prospectus may be obtained from the office of Goldman, Sachs & Co., 85 Broad Street, New York, NY 10004, 212-902-1000.

CONTACT: Daphne Jackson, 650-827-7071, or daphne@nrwpr.com, or Bryan Cohen, 650-827-7066, or bryan@nrwpr.com, both of Niehaus Ryan Wong, Inc., for PlantRx.com, Inc.; or Heather Whittemore Locke of PlanetRx.com, Inc, 650-616-1702, or heather.locke@planetrx.com; or investors, 650-616-1669, or Investorrelations@planetrx.com.

SOURCE: PlanetRx.com, Inc.

--------------------------------------------------------------------------------
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext